Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224880 · ClinicalTrials.gov registry record
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
A clinical trial of Skin Laxity and glp1 Agonist, sponsored by Cytrellis Biosystems.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT07224880 is a study of Skin Laxity and glp1 Agonist that is actively recruiting participants, run by Cytrellis Biosystems. The registered enrollment target is 10 participants, below the 190-participant average among 10 other Skin Laxity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07224880, a study of Skin Laxity and glp1 Agonist, is actively recruiting participants, sponsored by Cytrellis Biosystems.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of the study is to collect information about how the device functions in a variety of treatment areas and skin types and to find out what changes, if any, occur in the skin treated with the study device compared to the skin that wasn't treated including patients receiving GLP-1's, a class of medications that mimic a natural hormone to help control blood sugar and support weight loss. The study will also evaluate side effects that occur with this treatment, if any. Standardized 2D Imaging will be used to quantify reduction of wrinkle severity
Conditions Studied
Interventions
- DEVICE ellacor
Study Locations (1)
California
- Tri Valley Plastic Surgery - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07224880
The ClinicalTrials.gov registry entry for NCT07224880 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 10 other Skin Laxity trials with a reported enrollment target (95% lower). The listed sponsor is Cytrellis Biosystems, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which ellacor is the first listed.
NCT07224880 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07224880 about?
NCT07224880 is a clinical study titled "Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists". The main purpose of the study is to collect information about how the device functions in a variety of treatment areas and skin types and to find out what changes, if any, occur in the skin treated with the study device compared to the skin that wasn't treated including patients receiving GLP-1's, a...
What is the current status of trial NCT07224880?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-10-14. Estimated completion is 2026-02-28.
What conditions does trial NCT07224880 study?
This clinical trial studies the following conditions: Skin Laxity, glp1 Agonist, Gene Expression.
What interventions are being tested in trial NCT07224880?
The interventions under investigation include: ellacor (DEVICE).
Who is sponsoring clinical trial NCT07224880?
This trial is sponsored by Cytrellis Biosystems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224880 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.